Abstract
Off-label prescription is common in Europe and economically motivated off-label prescription is being increasingly recognised by the national laws of the Member States of the European Union, even though both European law and the European courts refute the prevalence of financial considerations over public health.
This article examines the causes of economically motivated off-label prescription, the current legislative and administrative measures implemented in several European countries and its consequences, and it concludes that in very specific scenarios off-label prescription grounded in economic reasons should be allowed.
Keywords
Fulltext
The full text of this article is available on PDF.
References
-
1.
The references of this article is available on PDF.
Copyright
© 2017, Journal of Health Reports and Technology. This open-access article is available under the Creative Commons Attribution-NonCommercial 4.0 (CC BY-NC 4.0) International License (https://creativecommons.org/licenses/by-nc/4.0/), which allows for the copying and redistribution of the material only for noncommercial purposes, provided that the original work is properly cited.